451 related articles for article (PubMed ID: 22019179)
1. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
Park JJ; Park BK; Park SY; Kim CK
J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
[TBL] [Abstract][Full Text] [Related]
3. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
Zhou W; Arellano RS
J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous cryoablation of masses in a solitary kidney.
Weisbrod AJ; Atwell TD; Frank I; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
AJR Am J Roentgenol; 2010 Jun; 194(6):1620-5. PubMed ID: 20489104
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
7. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous computed tomography-guided renal mass radiofrequency ablation versus cryoablation: doses of sedation medication used.
Truesdale CM; Soulen MC; Clark TW; Mondschein JI; Wehrenberg-Klee E; Malkowicz SB; Wein AJ; Guzzo TJ; Stavropoulos SW
J Vasc Interv Radiol; 2013 Mar; 24(3):347-50. PubMed ID: 23433410
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
Zhou W; Uppot RN; Feldman AS; Arellano RS
AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
Cool DW; Kachura JR
J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
[TBL] [Abstract][Full Text] [Related]
12. Cryoablation vs. radiofrequency ablation for small renal masses.
Pirasteh A; Snyder L; Boncher N; Passalacqua M; Rosenblum D; Prologo JD
Acad Radiol; 2011 Jan; 18(1):97-100. PubMed ID: 20880723
[TBL] [Abstract][Full Text] [Related]
13. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.
Permpongkosol S; Link RE; Solomon SB; Kavoussi LR
J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865
[TBL] [Abstract][Full Text] [Related]
14. Renal cryoablation of small renal masses: a Korea University experience.
Kim HK; Pyun JH; Kim JY; Kim SB; Cho S; Kang SG; Lee JG; Kim JJ; Cheon J; Kang SH
Korean J Urol; 2015 Feb; 56(2):117-24. PubMed ID: 25685298
[TBL] [Abstract][Full Text] [Related]
15. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations.
Allaf ME; Varkarakis IM; Bhayani SB; Inagaki T; Kavoussi LR; Solomon SB
Radiology; 2005 Oct; 237(1):366-70. PubMed ID: 16126920
[TBL] [Abstract][Full Text] [Related]
16. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
Zhou W; Herwald SE; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
[TBL] [Abstract][Full Text] [Related]
17. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of synchronous bilateral renal cell carcinoma.
Zhang S; Zhao X; Ji C; Liu G; Li X; Zhang G; Gan W; Guo H
Int J Urol; 2012 Mar; 19(3):241-7. PubMed ID: 22129157
[TBL] [Abstract][Full Text] [Related]
19. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
[TBL] [Abstract][Full Text] [Related]
20. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease.
Gobara H; Nakatsuka A; Shimizu K; Yamanaka T; Matsui Y; Iguchi T; Hiraki T; Yamakado K
Jpn J Radiol; 2019 Jun; 37(6):481-486. PubMed ID: 30941617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
